CUSIP: 36870A108
What is CUSIP 36870A108?
CUSIP 36870A108 identifies GEMP - GEMPHIRE THERAPEUTICS INC - COM in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 36870A108:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2019 Q4 | 0 | $0 | -$989,000 | 0 | |
| 2019 Q3 | 2,602,059 | $989,000 | -$745,307 | $0.38 | 18 |
| 2019 Q2 | 3,125,839 | $2,520,000 | -$160,053 | $0.81 | 18 |
| 2019 Q1 | 3,289,871 | $3,800,000 | -$261,270 | $1.15 | 19 |
| 2018 Q4 | 3,786,432 | $3,059,000 | -$630,643 | $0.80 | 22 |
| 2018 Q3 | 4,062,968 | $8,369,000 | -$22,570,585 | $2.06 | 24 |
| 2018 Q2 | 4,648,608 | $47,136,000 | -$1,167,810 | $10.19 | 37 |
| 2018 Q1 | 4,861,198 | $31,598,000 | +$9,654,533 | $6.51 | 28 |
| 2017 Q4 | 3,305,410 | $26,413,000 | -$879,756 | $7.95 | 28 |
| 2017 Q3 | 3,413,768 | $32,409,000 | +$1,558,013 | $9.50 | 25 |
| 2017 Q2 | 3,157,187 | $40,523,000 | +$2,754,958 | $12.80 | 27 |
| 2017 Q1 | 2,943,597 | $30,908,000 | +$16,983,859 | $10.50 | 16 |
| 2016 Q4 | 1,350,802 | $10,590,000 | -$305,417 | $7.83 | 10 |
| 2016 Q3 | 1,389,359 | $15,171,000 | +$15,171,000 | $10.92 | 12 |